Actions of annatto-extracted tocotrienol supplementation on obese postmenopausal women: study protocol for a double-blinded, placebo-controlled, randomised trial

Amir Aryaie, Grant Tinsley, Jaehoon Lee, Bruce A Watkins, Lane Moore, Adel Alhaj-Saleh, Kartik Shankar, Sarah R Wood, Rui Wang, Chwan-Li Shen, Amir Aryaie, Grant Tinsley, Jaehoon Lee, Bruce A Watkins, Lane Moore, Adel Alhaj-Saleh, Kartik Shankar, Sarah R Wood, Rui Wang, Chwan-Li Shen

Abstract

Introduction: Obesity is a major health concern in postmenopausal women, and chronic low-grade inflammation contributes to the development of obesity. Cellular studies and high-fat-diet-induced obese mouse model mimicking obesity show the antiobesity effect of annatto-extracted tocotrienols (TT) with antioxidant capability. We aim to assess the safety and efficacy of TT consumption for lipid-related parameters in obese postmenopausal women.

Methods and analysis: Eligible obese postmenopausal women will be randomly assigned to placebo group (430 mg olive oil) and TT group (DeltaGold Tocotrienol 70%) for 24 weeks. In the present study, the primary outcome is total/regional fat mass and visceral adipose tissue. The secondary outcomes include lipid profile in serum, mRNA expression of fatty acid synthase and carnitine palmitoyltransferase 1A in fat tissue, oxylipins and endocannabinoids in plasma and adipose tissue, abundance and composition of intestinal microbiome in faeces, high-sensitivity C-reactive protein (hs-CRP) in serum and leptin in serum. Every participant will be evaluated at 0 (prior to starting intervention) and 24 weeks of intervention, except for serum lipid profile and hs-CRP at 0, 12 and 24 weeks. 'Intent-to-treat' principle is employed for data analysis. Hierarchical linear modelling is used to estimate the effects of dietary TT supplementation while properly accounting for dependency of data and identified covariates. To our knowledge, this is the first randomised, placebo-controlled, double-blinded study to determine dietary TT supplementation on an obese population. If successful, this study will guide the future efficacy TT interventions and TT can be implemented as an alternative for obese population in antiobesity management.

Ethics and dissemination: This study has been approved by the Bioethics Committee of the Texas Tech University Health Sciences Center, Lubbock. An informed consent form will be signed by a participant before enrolling in the study. The results from this trial will be actively disseminated through academic conference presentation and peer-reviewed journals.

Trial registration number: NCT03705845.

Keywords: inflammation; lipid; microbiome; tocotrienols; women.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. New who report: deaths from noncommunicable diseases on the rise, with developing world hit hardest. Cent Eur J Public Health 2011;19:114–20.
    1. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011;29:415–45.10.1146/annurev-immunol-031210-101322
    1. Powell WS, Rokach J. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. Biochim Biophys Acta 2015;1851:340–55.10.1016/j.bbalip.2014.10.008
    1. Watkins BA, Kim J, Kenny A, et al. . Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets. Biochim Biophys Acta 2016;1861:1693–704.10.1016/j.bbalip.2016.07.007
    1. Kim J, Carlson ME, Kuchel GA, et al. . Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6J mice. Int J Obes 2016;40:129–37.10.1038/ijo.2015.135
    1. Heemskerk MM, Giera M, Bouazzaoui FE, et al. . Increased PUFA content and 5-lipoxygenase pathway expression are associated with subcutaneous adipose tissue inflammation in obese women with type 2 diabetes. Nutrients 2015;7:7676–90.10.3390/nu7095362
    1. Möller K, Ostermann AI, Rund K, et al. . Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects. Prostaglandins Leukot Essent Fatty Acids 2016;106:39–49.10.1016/j.plefa.2015.12.001
    1. Horrillo R, González-Périz A, Martínez-Clemente M, et al. . 5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J Immunol 2010;184:3978–87.10.4049/jimmunol.0901355
    1. Poeckel D, Funk CD. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res 2010;86:243–53.10.1093/cvr/cvq016
    1. Chakrabarti SK, Cole BK, Wen Y, et al. . 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes. Obesity 2009;17:1657–63.10.1038/oby.2009.192
    1. Dobrian AD, Lieb DC, Cole BK, et al. . Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 2011;50:115–31.10.1016/j.plipres.2010.10.005
    1. Nunemaker CS, Chen M, Pei H, et al. . 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am J Physiol Endocrinol Metab 2008;295:E1065–75.10.1152/ajpendo.90371.2008
    1. Sears DD, Miles PD, Chapman J, et al. . 12/15-Lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS One 2009;4:e725010.1371/journal.pone.0007250
    1. Börgeson E, Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol 2012;3:31810.3389/fimmu.2012.00318
    1. Newman JW, Pedersen TL, Brandenburg VR, et al. . Effect of omega-3 fatty acid ethyl esters on the oxylipin composition of lipoproteins in hypertriglyceridemic, statin-treated subjects. PLoS One 2014;9:e11147110.1371/journal.pone.0111471
    1. Suzuki YJ, Tsuchiya M, Wassall SR, et al. . Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 1993;32:10692–9.10.1021/bi00091a020
    1. Meydani M, Vitamin E. Vitamin E.. Lancet 1995;345:170–5.10.1016/S0140-6736(95)90172-8
    1. Burdeos GC, Nakagawa K, Kimura F, et al. . Tocotrienol attenuates triglyceride accumulation in HepG2 cells and F344 rats. Lipids 2012;47:471–81.10.1007/s11745-012-3659-0
    1. Allen L, Ramalingam L, Menikdiwela K, et al. . Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice. J Nutr Biochem 2017;48:128–37.10.1016/j.jnutbio.2017.07.003
    1. Wong W-Y, Poudyal H, Ward LC, et al. . Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients 2012;4:1527–41.10.3390/nu4101527
    1. Chou T-W, Ma C-Y, Cheng H-H, et al. . A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr 2009;45:29–36.10.3164/jcbn.08-257
    1. Das S, Mukherjee S, Lekli I, et al. . Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics. Mol Cell Biochem 2012;360:35–45.10.1007/s11010-011-1041-9
    1. Qureshi AA, Qureshi N, Hasler-Rapacz JO, et al. . Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 1991;53:1042S–6.10.1093/ajcn/53.4.1042S
    1. Watkins T, Lenz P, Gapor A, et al. . Gamma-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 1993;28:1113–8.10.1007/BF02537079
    1. Wong RSY, Radhakrishnan AK, Ibrahim TAT, et al. . δ- and γ-tocotrienols induce classical ultrastructural apoptotic changes in human T lymphoblastic leukemic cells. Microsc Microanal 2012;18:462–9.10.1017/S1431927612000177
    1. Budin SB, Othman F, Louis SR, et al. . The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics 2009;64:235-4410.1590/S1807-59322009000300015
    1. Heng EC, Karsani SA, Abdul Rahman M, et al. . Supplementation with tocotrienol-rich fraction alters the plasma levels of apolipoprotein A-I precursor, apolipoprotein E precursor, and C-reactive protein precursor from young and old individuals. Eur J Nutr 2013;52:1811–20.10.1007/s00394-012-0485-3
    1. Qureshi AA, Bradlow BA, Brace L, et al. . Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 1995;30:1171–7.10.1007/BF02536620
    1. Qureshi AA, Khan DA, Mahjabeen W, et al. . Qureshi, dose-dependent modulation of lipid parameters, cytokines and RNA by ¦Ä-tocotrienol in hypercholesterolemic subjects restricted to AHA Step-1 diet, 2015 2015.
    1. Qureshi AA, Khan DA, Mahjabeen W, et al. . Impact of δ-tocotrienol on inflammatory biomarkers and oxidative stress in hypercholesterolemic subjects, Journal of clinical and experimental cardiology 2015;6.
    1. Zaiden N, Yap WN, Ong S, et al. . Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion. J Atheroscler Thromb 2010;17:1019–32.10.5551/jat.4911
    1. Haghighat N, Vafa M, Eghtesadi S, et al. . The effects of tocotrienols added to canola oil on microalbuminuria, inflammation, and nitrosative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Int J Prev Med 2014;5:617–23.
    1. Irandoost P, Ebrahimi-Mameghani M, Pirouzpanah S. Does grape seed oil improve inflammation and insulin resistance in overweight or obese women? Int J Food Sci Nutr 2013;64:706–10.10.3109/09637486.2013.775228
    1. Aggarwal BB, Sundaram C, Prasad S, et al. . Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol 2010;80:1613–31.10.1016/j.bcp.2010.07.043
    1. Shen C-L, Yang S, Tomison MD, et al. . Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial. Osteoporosis International 2018;29:881–91.10.1007/s00198-017-4356-x
    1. Craig CL, Marshall AL, Sjöström M, et al. . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95.10.1249/01.MSS.0000078924.61453.FB
    1. Choquette S, Riesco Éléonor, Cormier Éric, et al. . Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. Br J Nutr 2011;105:1199–209.10.1017/S0007114510004897
    1. Pervez MA, Khan DA, Ijaz A, et al. . Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease. Turk J Gastroenterol 2018;29:170–6.10.5152/tjg.2018.17297
    1. Wong W-Y, Ward LC, Fong CW, et al. . Anti-Inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats. Eur J Nutr 2017;56:133–50.10.1007/s00394-015-1064-1
    1. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Faseb J 2008;22:659–61.10.1096/fj.07-9574LSF
    1. Mahipal A, Klapman J, Vignesh S, et al. . Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites. Cancer Chemother Pharmacol 2016;78:157–65.10.1007/s00280-016-3048-0
    1. Shen C-L, Mo H, Yang S, et al. . Safety and efficacy of tocotrienol supplementation for bone health in postmenopausal women: protocol for a dose-response double-blinded placebo-controlled randomised trial. BMJ Open 2016;6:e01257210.1136/bmjopen-2016-012572
    1. Shen C-L, Wang S, Yang S, et al. . A 12-week evaluation of annatto tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake. BMC Complement Altern Med 2018;18:19810.1186/s12906-018-2263-0
    1. Tinsley GM. Proportional bias between dual-energy X-ray absorptiometry and bioelectrical impedance analysis varies based on sex in active adults consuming high- and low-carbohydrate diets. Nutr Res 2017;42:85–100.10.1016/j.nutres.2017.05.003
    1. Tinsley GM. Reliability and agreement between DXA-derived body volumes and their usage in 4-compartment body composition models produced from DXA and BIA values. J Sports Sci 2018;36:1235–40.10.1080/02640414.2017.1369556
    1. Shen C-L, Yang S, Tomison MD, et al. . Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial. Osteoporos Int 2018;29:881–91.10.1007/s00198-017-4356-x
    1. Christodoulides C, Lagathu C, Sethi JK, et al. . And Wnt signalling. Trends Endocrinol Metab 2009;20:16–24.
    1. Heinonen S, Buzkova J, Muniandy M, et al. . Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes 2015;64:3135–45.10.2337/db14-1937
    1. Walhin J-P, Richardson JD, Betts JA, et al. . Exercise counteracts the effects of short-term overfeeding and reduced physical activity independent of energy imbalance in healthy young men. J Physiol 2013;591:6231–43.10.1113/jphysiol.2013.262709
    1. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8.10.1006/meth.2001.1262
    1. Watkins BA. Endocannabinoids, exercise, pain, and a path to health with aging. Mol Aspects Med 2018;64:68–78.10.1016/j.mam.2018.10.001
    1. Al-Obaide MAI, Singh R, Datta P, et al. . Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD. J Clin Med 2017;6. doi:10.3390/jcm6090086. [Epub ahead of print: 19 Sep 2017].
    1. Enders CK. Applied missing data analysis. New York: Guilford Publications, 2010.
    1. Capitanio D, Vasso M, De Palma S, et al. . Specific protein changes contribute to the differential muscle mass loss during ageing. Proteomics 2016;16:645–56.10.1002/pmic.201500395
    1. Adams GR, Hather BM, Baldwin KM, et al. . Skeletal muscle myosin heavy chain composition and resistance training. J Appl Physiol 1993;74:911–5.10.1152/jappl.1993.74.2.911
    1. Wehrens R. Chemometrics with R multivariate data analysis in the natural sciences and life sciences 2011.
    1. Mevik B-H, Wehrens R. The PLS package: principal component and partial least squares regression in R 2007;18:23.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner